Gainers
- aTyr Pharma LIFE stock increased by 13.77% to $10.41 during Monday's after-market session. Trading volume for this security closed at 5.2 million, accounting for 2734.81% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $176.1 million.
- NRX Pharmaceuticals NRXP shares moved upwards by 8.83% to $11.95. Trading volume for this security closed at 120.1K, accounting for 2.55% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $613.4 million.
- Olema Pharmaceuticals OLMA shares increased by 6.63% to $29.75. The company's market cap stands at $1.1 billion.
- Kiromic BioPharma KRBP shares rose 5.64% to $3.74. The company's market cap stands at $57.7 million.
- Soleno Therapeutics SLNO stock increased by 4.27% to $0.94. The company's market cap stands at $74.9 million.
- Opiant Pharmaceuticals OPNT shares moved upwards by 3.01% to $18.82. The company's market cap stands at $82.8 million.
Losers
- Biomerica BMRA shares declined by 9.04% to $4.13 during Monday's after-market session. The market value of their outstanding shares is at $51.6 million.
- Advaxis ADXS stock decreased by 2.51% to $0.55. Today's trading volume for this security ended up closing at 71.2K shares, which is 0.88 percent of its average volume over the last 100 days. The company's market cap stands at $79.5 million. As per the press release, Q3 earnings came out yesterday.
- Soligenix SNGX stock declined by 1.86% to $1.06. The market value of their outstanding shares is at $42.5 million.
- Agile Therapeutics AGRX stock fell 1.84% to $1.07. The market value of their outstanding shares is at $99.5 million.
- Leap Therapeutics LPTX shares declined by 1.7% to $1.74. Trading volume for this security closed at 193.6K, accounting for 34.35% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $103.8 million.
- CohBar CWBR shares declined by 1.7% to $1.16. The market value of their outstanding shares is at $74.7 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in